• IRLAB Therapeutics reported 148,711,921 shares outstanding as of Aug. 31, 2026, matching total voting rights of 148,711,921.
• Share count comprises 148,632,145 series A ordinary shares, 79,776 series B ordinary shares; each share carries one vote.
• Change reflects completion of a rights issue, including an overallotment issue of series A shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IRLAB Therapeutics AB published the original content used to generate this news brief on August 31, 2026, and is solely responsible for the information contained therein.